CN102827912A - 两酶一步法制备医药中间体d-7-aca的工艺 - Google Patents
两酶一步法制备医药中间体d-7-aca的工艺 Download PDFInfo
- Publication number
- CN102827912A CN102827912A CN2012103166993A CN201210316699A CN102827912A CN 102827912 A CN102827912 A CN 102827912A CN 2012103166993 A CN2012103166993 A CN 2012103166993A CN 201210316699 A CN201210316699 A CN 201210316699A CN 102827912 A CN102827912 A CN 102827912A
- Authority
- CN
- China
- Prior art keywords
- immobilization
- enzyme
- aca
- sodium salt
- cephalosporin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 66
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 56
- 238000000034 method Methods 0.000 title claims abstract description 45
- 238000005516 engineering process Methods 0.000 title claims abstract description 26
- 239000003814 drug Substances 0.000 title claims abstract description 13
- 239000000969 carrier Substances 0.000 title abstract description 5
- 239000000758 substrate Substances 0.000 claims abstract description 7
- 229930186147 Cephalosporin Natural products 0.000 claims description 43
- 229940124587 cephalosporin Drugs 0.000 claims description 43
- -1 cephalosporin sodium salt Chemical class 0.000 claims description 35
- 108090000371 Esterases Proteins 0.000 claims description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 24
- 239000006166 lysate Substances 0.000 claims description 24
- 230000008569 process Effects 0.000 claims description 24
- 230000002255 enzymatic effect Effects 0.000 claims description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 18
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 18
- 230000009089 cytolysis Effects 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 16
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 238000002425 crystallisation Methods 0.000 claims description 11
- 239000003085 diluting agent Substances 0.000 claims description 11
- 238000005336 cracking Methods 0.000 claims description 10
- 230000001105 regulatory effect Effects 0.000 claims description 9
- 238000001291 vacuum drying Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 7
- 230000003197 catalytic effect Effects 0.000 claims description 3
- 238000010790 dilution Methods 0.000 claims description 3
- 239000012895 dilution Substances 0.000 claims description 3
- 239000013078 crystal Substances 0.000 claims description 2
- 238000005304 joining Methods 0.000 claims description 2
- 230000000384 rearing effect Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 17
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract description 5
- 239000006227 byproduct Substances 0.000 abstract description 3
- 238000000855 fermentation Methods 0.000 abstract description 3
- 230000004151 fermentation Effects 0.000 abstract description 3
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N Cephalosporin C Natural products S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 abstract 5
- 239000012141 concentrate Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 238000004904 shortening Methods 0.000 abstract 1
- HZWLVUKHUSRPCG-OOARYINLSA-M sodium;(6r,7r)-3-(acetyloxymethyl)-7-[[(5r)-5-azaniumyl-5-carboxylatopentanoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound [Na+].S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H]([NH3+])C([O-])=O)[C@@H]12 HZWLVUKHUSRPCG-OOARYINLSA-M 0.000 abstract 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- 239000000047 product Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 14
- 150000001780 cephalosporins Chemical class 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- 230000008025 crystallization Effects 0.000 description 6
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 description 5
- 238000004811 liquid chromatography Methods 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 102000004674 D-amino-acid oxidase Human genes 0.000 description 4
- 108010003989 D-amino-acid oxidase Proteins 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000005265 energy consumption Methods 0.000 description 3
- 108010034416 glutarylamidocephalosporanic acid acylase Proteins 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- SUBPBOVIYZLZKW-SSDOTTSWSA-N (2r)-4-(3-carboxypropyl)piperazine-2-carboxylic acid Chemical compound OC(=O)CCCN1CCN[C@@H](C(O)=O)C1 SUBPBOVIYZLZKW-SSDOTTSWSA-N 0.000 description 2
- NVIAYEIXYQCDAN-CLZZGJSISA-N 7beta-aminodeacetoxycephalosporanic acid Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](N)[C@@H]12 NVIAYEIXYQCDAN-CLZZGJSISA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- GNWUOVJNSFPWDD-XMZRARIVSA-M Cefoxitin sodium Chemical compound [Na+].N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)CC1=CC=CS1 GNWUOVJNSFPWDD-XMZRARIVSA-M 0.000 description 1
- 239000005046 Chlorosilane Substances 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229960002682 cefoxitin Drugs 0.000 description 1
- LTINZAODLRIQIX-FBXRGJNPSA-N cefpodoxime proxetil Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC)C(=O)OC(C)OC(=O)OC(C)C)C(=O)C(=N/OC)\C1=CSC(N)=N1 LTINZAODLRIQIX-FBXRGJNPSA-N 0.000 description 1
- 229960004797 cefpodoxime proxetil Drugs 0.000 description 1
- KOPOQZFJUQMUML-UHFFFAOYSA-N chlorosilane Chemical compound Cl[SiH3] KOPOQZFJUQMUML-UHFFFAOYSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Landscapes
- Cephalosporin Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210316699.3A CN102827912B (zh) | 2012-08-31 | 2012-08-31 | 两酶一步法制备医药中间体d-7-aca的工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210316699.3A CN102827912B (zh) | 2012-08-31 | 2012-08-31 | 两酶一步法制备医药中间体d-7-aca的工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102827912A true CN102827912A (zh) | 2012-12-19 |
CN102827912B CN102827912B (zh) | 2014-06-25 |
Family
ID=47331219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210316699.3A Active CN102827912B (zh) | 2012-08-31 | 2012-08-31 | 两酶一步法制备医药中间体d-7-aca的工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102827912B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104651439A (zh) * | 2015-03-23 | 2015-05-27 | 石药集团中诺药业(石家庄)有限公司 | 一种7-氨基头孢烷酸的酶法制备工艺 |
CN104845991A (zh) * | 2015-03-12 | 2015-08-19 | 深圳大学 | 一种cpc酰化酶重组表达系统的构建与应用 |
CN105087537A (zh) * | 2015-09-16 | 2015-11-25 | 山东鲁抗立科药业有限公司 | 一种7-aca固定化酶lk118的制备及其使用方法 |
CN104480181B (zh) * | 2014-12-31 | 2018-07-20 | 华北制药河北莱欣药业有限公司 | 3-去乙酰基-7-氨基头孢烯酸的制备方法 |
CN110214188A (zh) * | 2016-08-26 | 2019-09-06 | 艾美科健株式会社 | 7-氨基头孢烷酸的高浓度生产重组顶头孢霉菌株的制造方法及利用其方法所制造的菌株 |
CN110964770A (zh) * | 2018-09-29 | 2020-04-07 | 北京科技大学 | 连续制备3-去乙酰-7-氨基头孢烷酸的方法 |
CN114540454A (zh) * | 2022-03-09 | 2022-05-27 | 浙江东邦药业有限公司 | 一种酶法合成盐酸头孢卡品匹酯的方法及其合成中间体 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101654694A (zh) * | 2008-08-22 | 2010-02-24 | 湖南福来格生物技术有限公司 | 一种3-去乙酰基-7-氨基头孢烯酸的制备方法 |
CN101724678A (zh) * | 2009-12-08 | 2010-06-09 | 石药集团河北中润制药有限公司 | 一种3-去乙酰基-7-氨基头孢烷酸的制备方法 |
CN102321721A (zh) * | 2011-10-25 | 2012-01-18 | 石药集团河北中润制药有限公司 | 一种制备3-去乙酰基-7-氨基头孢烷酸的工艺 |
CN102505035A (zh) * | 2011-10-25 | 2012-06-20 | 石药集团河北中润制药有限公司 | 一种3-去乙酰基-7-氨基头孢烷酸的制备工艺 |
-
2012
- 2012-08-31 CN CN201210316699.3A patent/CN102827912B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101654694A (zh) * | 2008-08-22 | 2010-02-24 | 湖南福来格生物技术有限公司 | 一种3-去乙酰基-7-氨基头孢烯酸的制备方法 |
CN101724678A (zh) * | 2009-12-08 | 2010-06-09 | 石药集团河北中润制药有限公司 | 一种3-去乙酰基-7-氨基头孢烷酸的制备方法 |
CN102321721A (zh) * | 2011-10-25 | 2012-01-18 | 石药集团河北中润制药有限公司 | 一种制备3-去乙酰基-7-氨基头孢烷酸的工艺 |
CN102505035A (zh) * | 2011-10-25 | 2012-06-20 | 石药集团河北中润制药有限公司 | 一种3-去乙酰基-7-氨基头孢烷酸的制备工艺 |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104480181B (zh) * | 2014-12-31 | 2018-07-20 | 华北制药河北莱欣药业有限公司 | 3-去乙酰基-7-氨基头孢烯酸的制备方法 |
CN104845991A (zh) * | 2015-03-12 | 2015-08-19 | 深圳大学 | 一种cpc酰化酶重组表达系统的构建与应用 |
CN104651439A (zh) * | 2015-03-23 | 2015-05-27 | 石药集团中诺药业(石家庄)有限公司 | 一种7-氨基头孢烷酸的酶法制备工艺 |
CN105087537A (zh) * | 2015-09-16 | 2015-11-25 | 山东鲁抗立科药业有限公司 | 一种7-aca固定化酶lk118的制备及其使用方法 |
CN105087537B (zh) * | 2015-09-16 | 2018-09-28 | 艾美科健(中国)生物医药有限公司 | 一种7-aca固定化酶lk118的制备及其使用方法 |
CN110214188A (zh) * | 2016-08-26 | 2019-09-06 | 艾美科健株式会社 | 7-氨基头孢烷酸的高浓度生产重组顶头孢霉菌株的制造方法及利用其方法所制造的菌株 |
CN110214188B (zh) * | 2016-08-26 | 2023-06-06 | 艾美科健株式会社 | 7-氨基头孢烷酸的高浓度生产重组顶头孢霉菌株的制造方法及利用其方法所制造的菌株 |
CN110964770A (zh) * | 2018-09-29 | 2020-04-07 | 北京科技大学 | 连续制备3-去乙酰-7-氨基头孢烷酸的方法 |
CN114540454A (zh) * | 2022-03-09 | 2022-05-27 | 浙江东邦药业有限公司 | 一种酶法合成盐酸头孢卡品匹酯的方法及其合成中间体 |
CN114540454B (zh) * | 2022-03-09 | 2023-10-17 | 浙江东邦药业有限公司 | 一种酶法合成盐酸头孢卡品匹酯的方法及其合成中间体 |
Also Published As
Publication number | Publication date |
---|---|
CN102827912B (zh) | 2014-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102827912B (zh) | 两酶一步法制备医药中间体d-7-aca的工艺 | |
CN106191170B (zh) | 一种酶法制备三磷酸腺苷的方法 | |
CN109134594B (zh) | 一种酶法制备谷胱甘肽的方法 | |
CN102605014B (zh) | 一种l-2-氨基丁酸的生物制备方法 | |
CN104004002B (zh) | 一种由青霉素发酵液直接制备6-氨基青霉烷酸的方法 | |
CN102321721B (zh) | 一种制备3-去乙酰基-7-氨基头孢烷酸的工艺 | |
CN104928340A (zh) | 一种酶法合成头孢丙烯的工艺 | |
CN106086126A (zh) | 一种酶催化合成谷胱甘肽的方法 | |
CN111039861A (zh) | 一种含低烟酸副产物的烟酰胺合成催化工艺 | |
CN103571907B (zh) | 一种酶法合成头孢克洛的分离及纯化方法 | |
CN101724678A (zh) | 一种3-去乙酰基-7-氨基头孢烷酸的制备方法 | |
CN102505035B (zh) | 一种3-去乙酰基-7-氨基头孢烷酸的制备工艺 | |
CN104480181A (zh) | 3-去乙酰基-7-氨基头孢烯酸的制备方法 | |
CN104447800A (zh) | 一种头孢西丁酸的合成技术 | |
CN102286563A (zh) | 一种采用固定化酶制备l-鸟氨酸的方法 | |
CN102286597A (zh) | 一种制备7-氨基头孢烷酸的方法 | |
CN106011191B (zh) | 一种全细胞生物催化生产5-氨基戊酸的方法 | |
CN104496937A (zh) | 头孢他啶侧链酸活性酯的合成方法 | |
CN104830940A (zh) | 一种酶法合成阿莫西林的工艺 | |
CN104263772B (zh) | 一种基于生物酶制备乙酰磷酸盐的方法 | |
CN104178540A (zh) | 一种生物催化法合成腺苷蛋氨酸的方法 | |
CN108004272B (zh) | 一种利用三孢布拉氏霉菌制备番茄红素的方法及番茄红素制品 | |
CN101104862B (zh) | 非均相酶催化水解5-芳基海因合成d-芳基甘氨酸的方法 | |
CN101348808B (zh) | 鸟氨酸盐酸盐的双酶耦合制备方法 | |
CN103772415B (zh) | 一种由7-氨基头孢烷酸一步法制备头孢洛宁的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 272073 Shandong city of Jining province high tech Zone Shixian Road No. 1688 Patentee after: AMICOGEN (CHINA) BIOPHARM CO.,LTD. Address before: 272000 Shandong city of Jining province high tech Zone East Ring Road Lukang International Industrial Park Patentee before: SHANDONG LUKANG RECORD PHARMACEUTICALS Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of pharmaceutical intermediate d-7-aca by two enzyme one step method Effective date of registration: 20200730 Granted publication date: 20140625 Pledgee: Jining City branch of the China Co truction Bank Corp. Pledgor: AMICOGEN (CHINA) BIOPHARM Co.,Ltd. Registration number: Y2020980004549 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20211115 Granted publication date: 20140625 Pledgee: Jining City branch of the China Co truction Bank Corp. Pledgor: AMICOGEN (CHINA) BIOPHARM CO.,LTD. Registration number: Y2020980004549 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of pharmaceutical intermediate d-7-aca by two enzyme one-step method Effective date of registration: 20211201 Granted publication date: 20140625 Pledgee: Jining City branch of the China Co truction Bank Corp. Pledgor: AMICOGEN (CHINA) BIOPHARM CO.,LTD. Registration number: Y2021980013624 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221115 Granted publication date: 20140625 Pledgee: Jining City branch of the China Co truction Bank Corp. Pledgor: AMICOGEN (CHINA) BIOPHARM CO.,LTD. Registration number: Y2021980013624 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of pharmaceutical intermediate D-7-ACA by one step two enzyme method Effective date of registration: 20221117 Granted publication date: 20140625 Pledgee: Jining City branch of the China Co truction Bank Corp. Pledgor: AMICOGEN (CHINA) BIOPHARM CO.,LTD. Registration number: Y2022980022253 |